Harvest Volatility Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,940
Closed -$1.53M 47
2023
Q2
$1.53M Sell
11,940
-1,938
-14% -$234K 0.31% 58
2023
Q1
$1.59M Sell
13,878
-2,415
-15% -$270K 0.32% 62
2022
Q4
$1.85M Sell
16,293
-4,529
-22% -$497K 0.37% 55
2022
Q3
$1.71M Sell
20,822
-327
-2% -$27.7K 0.3% 71
2022
Q2
$1.58M Sell
21,149
-2,499
-11% -$228K 0.25% 84
2022
Q1
$3.02M Buy
23,648
+23,624
+98,433% +$2.58M 0.34% 55
2021
Q4
$3.17K Sell
24
-17,800
-100% -$2.56M ﹤0.01% 75
2021
Q3
$2.44M Buy
17,824
+6,708
+60% +$846K 0.11% 55
2021
Q2
$1.19M Buy
11,116
+2,780
+33% +$267K 0.1% 79
2021
Q1
$749K Buy
8,336
+3,176
+62% +$298K 0.07% 93
2020
Q4
$477K Buy
+5,160
New +$461K 0.06% 88

Other funds holding DXCM

Harvest Volatility Management's DXCM Position: Q3 2023 in Review

Harvest Volatility Management sold out of DexCom (DXCM) in Q3 2023, closing a stake of 11,940 shares — an estimated $1.53M sold.

Harvest Volatility Management first reported a position in DXCM in Q4 2020 and held it in 11 quarters. The position peaked at $3.02M in Q1 2022. 902 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Harvest Volatility Management reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Harvest Volatility Management sold 11,940 DexCom shares in Q3 2023, an estimated $1.53M.
  • Harvest Volatility Management first reported a position in DexCom in Q4 2020 and held it in 11 quarters.
  • Harvest Volatility Management's DexCom position peaked at $3.02M in Q1 2022.
  • 902 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Harvest Volatility Management's 13F filing for Q3 2023, filed 7 Nov 2023.